DE69906974D1 - Thixotrope formulierungen zur befüllung von gelatinekapseln - Google Patents

Thixotrope formulierungen zur befüllung von gelatinekapseln

Info

Publication number
DE69906974D1
DE69906974D1 DE69906974T DE69906974T DE69906974D1 DE 69906974 D1 DE69906974 D1 DE 69906974D1 DE 69906974 T DE69906974 T DE 69906974T DE 69906974 T DE69906974 T DE 69906974T DE 69906974 D1 DE69906974 D1 DE 69906974D1
Authority
DE
Germany
Prior art keywords
filling
compositions
thixotrope
formulations
consistency
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69906974T
Other languages
English (en)
Other versions
DE69906974T2 (de
Inventor
Pascal Lombardin
Jean-Louis Grossiord
Monique Seiller
Elie Leverd
Eric Goutay
Jo L Bougaret
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Application granted granted Critical
Publication of DE69906974D1 publication Critical patent/DE69906974D1/de
Publication of DE69906974T2 publication Critical patent/DE69906974T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
DE69906974T 1998-07-07 1999-07-05 Thixotrope formulierungen zur befüllung von gelatinekapseln Expired - Fee Related DE69906974T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9808664 1998-07-07
FR9808664A FR2781373B1 (fr) 1998-07-07 1998-07-07 Formulations thixotropes pour le remplissage de gelules
PCT/FR1999/001614 WO2000001371A1 (fr) 1998-07-07 1999-07-05 Formulations thixotropes pour le remplissage de gelules

Publications (2)

Publication Number Publication Date
DE69906974D1 true DE69906974D1 (de) 2003-05-22
DE69906974T2 DE69906974T2 (de) 2004-02-26

Family

ID=9528339

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69906974T Expired - Fee Related DE69906974T2 (de) 1998-07-07 1999-07-05 Thixotrope formulierungen zur befüllung von gelatinekapseln

Country Status (15)

Country Link
US (1) US6709675B1 (de)
EP (1) EP1094791B1 (de)
JP (1) JP2002519370A (de)
CN (1) CN1211124C (de)
AT (1) ATE237318T1 (de)
AU (1) AU760665B2 (de)
BR (1) BR9911905A (de)
CA (1) CA2337273A1 (de)
DE (1) DE69906974T2 (de)
DK (1) DK1094791T3 (de)
ES (1) ES2197647T3 (de)
FR (1) FR2781373B1 (de)
PT (1) PT1094791E (de)
WO (1) WO2000001371A1 (de)
ZA (1) ZA200100052B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0212299B1 (pt) * 2001-09-10 2016-03-15 Hoffmann La Roche veículo tixotrópico oleoso, seu processo de preparação, massa de enchimento, e dose unitária farmacêutica
US20040242729A1 (en) * 2003-05-30 2004-12-02 3M Innovative Properties Company Stabilized particle dispersions containing surface-modified inorganic nanoparticles
US7459146B2 (en) * 2003-05-30 2008-12-02 3M Innovative Properties Company Stabilized aerosol dispersions
US7109247B2 (en) 2003-05-30 2006-09-19 3M Innovative Properties Company Stabilized particle dispersions containing nanoparticles
WO2005000279A1 (ja) * 2003-06-27 2005-01-06 Wakunaga Pharmaceutical Co., Ltd. 硬カプセル剤
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
US8318210B2 (en) * 2005-02-28 2012-11-27 Neos Therapeutics, Lp Compositions and methods of making sustained release liquid formulations
CA2611724C (en) 2005-06-10 2014-07-29 Pierre Fabre Medicament S.A. Stabilized milnacipran formulation
CN100335135C (zh) * 2005-11-04 2007-09-05 天津太平洋制药有限公司 银杏叶提取物胶囊组合物及其制备方法
US20080319083A1 (en) * 2006-01-27 2008-12-25 Asahi Kasei Pharma Corporation Medicine for transnasal administration
WO2008088601A2 (en) * 2007-01-16 2008-07-24 Texas Tech University System Method and apparatus for gender selection based on ph
DE102007055341A1 (de) * 2007-11-19 2009-05-20 Bayer Animal Health Gmbh Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren
EP2575784B1 (de) * 2010-06-02 2018-08-08 Astellas Deutschland GmbH Orale darreichungsform von bendamustin
US8978783B2 (en) 2011-05-26 2015-03-17 Smith International, Inc. Jet arrangement on an expandable downhole tool
US20160331695A1 (en) * 2014-01-31 2016-11-17 Fuji Capsule Co., Ltd. Capsule Formulation
DE102016109669A1 (de) 2016-05-25 2017-11-30 Tiernahrung Deuerer Gmbh Verfahren zum Herstellen eines Tiernahrungsproduktes
ES2960541T3 (es) 2017-10-19 2024-03-05 Signpath Pharma Inc Composiciones líquidas para una utilización peroral que comprenden derivados de fosfatidilglicerol y excipientes tixotrópicos para tratar canalopatías cardíacas causadas por agentes farmacológicos

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4202888A (en) * 1976-07-12 1980-05-13 Kali-Chemie Pharma Gmbh. Readily enterally absorbable pharmaceutical compositions of cardiac glycosides and preparation thereof
USH672H (en) * 1986-12-31 1989-09-05 E. R. Squibb & Sons, Inc. Stable antifungal capsule formulation
EP0461290B1 (de) * 1990-06-14 1994-01-12 HENNING BERLIN GmbH CHEMIE- UND PHARMAWERK Flüssig befüllte Steckkapselpräparate
EP0517412A1 (de) * 1991-06-03 1992-12-09 MERCK SHARP & DOHME LTD. Pharmazeutische Zusammensetzungen enthaltend eine Benzodiazepen
GB9325445D0 (en) * 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
US5545628A (en) * 1995-01-10 1996-08-13 Galephar P.R. Inc. Pharmaceutical composition containing fenofibrate
CN1191480A (zh) * 1995-06-09 1998-08-26 R·P·谢勒公司 含颗粒材料的软明胶胶囊
US5993858A (en) * 1996-06-14 1999-11-30 Port Systems L.L.C. Method and formulation for increasing the bioavailability of poorly water-soluble drugs
TW426516B (en) * 1996-12-06 2001-03-21 Fujisawa Pharmaceutical Co An oral pharmaceutical composition in solid dispersion containing water-insoluble tricyclic compounds
FR2761265B1 (fr) * 1997-03-28 1999-07-02 Sanofi Sa Composition pharmaceutique pour l'administration orale d'un derive du n-piperidino-3-pyrazolecarboxamide, de ses sels et de leurs solvates
US6171615B1 (en) * 1998-07-06 2001-01-09 Gattefoss{acute over (e)} Sustained release theophylline formulations, excipient systems and methods of production
US6365181B1 (en) * 2000-04-20 2002-04-02 Gattefosse Corporation Thixatropic gelatin carrier composition

Also Published As

Publication number Publication date
DK1094791T3 (da) 2003-08-11
JP2002519370A (ja) 2002-07-02
PT1094791E (pt) 2003-08-29
ES2197647T3 (es) 2004-01-01
ATE237318T1 (de) 2003-05-15
EP1094791B1 (de) 2003-04-16
AU760665B2 (en) 2003-05-22
DE69906974T2 (de) 2004-02-26
CN1308522A (zh) 2001-08-15
CN1211124C (zh) 2005-07-20
ZA200100052B (en) 2001-07-16
AU4622799A (en) 2000-01-24
EP1094791A1 (de) 2001-05-02
BR9911905A (pt) 2001-03-27
CA2337273A1 (fr) 2000-01-13
FR2781373B1 (fr) 2001-09-21
US6709675B1 (en) 2004-03-23
WO2000001371A1 (fr) 2000-01-13
FR2781373A1 (fr) 2000-01-28

Similar Documents

Publication Publication Date Title
DE69906974D1 (de) Thixotrope formulierungen zur befüllung von gelatinekapseln
ATE429210T1 (de) Orale flüssige zusammensetzungen
ATE235235T1 (de) Arzneistoffverabreichungssystem auf basis von flüssigkristall-strukturen
DE60023520D1 (de) Flüssiges hochvisköses system mit gesteuerter freisetzung und medizinische oder chirurgische vorrichtung
WO2004052336A3 (en) High viscosity liquid controlled delivery system and medical or surgical device
SV2004001556A (es) Preparaciones acidas de insulina con establidad mejorada
EE200300109A (et) Protsess vedela emulsioonkompositsiooni valmistamiseks ja emulsiooni kontsentraadi valmistamiseks, farmatseutiline kompositsioon, emulsiooni kontsentraat, komplekt ja emulsioonkompositsioon
ES2172003T3 (es) Formulacion oral de liberacion retardada inmediata y metodo para su preparacion.
ES2173708T3 (es) Composicion filmogena que comprende un poliuretano en dispersion acuosa y un agente plastificante.
EA200601588A1 (ru) Стабилизированные перенасыщенные твёрдые растворы липофильных лекарственных средств
ECSP067062A (es) Derivados de pirazol, composiciones que contienen dichos compuestos y procedimientos de uso
TW200605882A (en) Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof
AR003940A1 (es) Nuevas 1-fenilpirazol-3-carboxamidas substituidas que tienen una gran afinidad por los receptores humanos de la neurotensina, un procedimiento parasu preparacion y composiciones farmaceuticas que las contienen como principios activos.
UY29701A1 (es) Formulaciones líquidas para la administración controlada de derivados de bencisoxazol
Singh et al. Formulation development & evaluation of topical gel formulations using different gelling agents and its comparison with marketed gel formulation
PL1952142T3 (pl) Kompozycja do rozpuszczania do badania rozpuszczalności leku
ES2188011T3 (es) Agente de contraste para la reproduccion en imagenes de infartos y necrosis.
DK1267833T3 (da) Farmaceutiske præparater og fremgangsmåde til fremstilling deraf
BRPI0510694A (pt) composições farmacêuticas compreendendo ingredientes ativos concentrados encapsuladas em gelatina mole
ATE293964T1 (de) Zusammensetzungen und verfahren zur behinderung der entladung von nematokyste
DZ3459A1 (fr) Derives de 2h-1-benzopyran, procedes de preparation de ces derniers et compositions pharmaceutiques dans lesquels ils entrent.
Szűts et al. Study of the effects of drugs on the structures of sucrose esters and the effects of solid-state interactions on drug release
EP3354283A3 (de) Pharmazeutische kapselzusammensetzung mit silodosin
DK30581A (da) Fremgangsmaade til fremstilling af 5-aminotetrazolderivater af retinsyrer
ATE329578T1 (de) Pharmazeutische zusammensetzung enthaltend xanthangummi

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee